Abstract: An air conditioner housing of a vehicle includes a body having an internal space through which air flows and having a heat exchanger mounted at the internal space. The heat exchanger cools the air. A discharge port is at a lower end of the body and provides fluid communication between the internal space and an exterior of the body and discharges condensate water generated from the heat exchanger to the exterior. A plurality of blocking portions is disposed around the discharge port and protrudes into the internal space, thereby preventing foreign substances inside the body from directly blocking the discharge port.

Abstract: An air conditioner for a vehicle with an improved structure so that hot air is not directly discharged to a defrost vent in a floor mode or a mix mode, includes an air conditioning case in which an air flow path is formed, and a cooling heat exchanger and a heating heat exchanger provided sequentially on the air flow path of the air conditioning case in an airflow direction, wherein a defrost vent, a face vent, and a floor vent are formed on the air conditioning case, wherein the defrost vent includes a first defogging flow path allowing air passing through the heating heat exchanger to be discharged directly, and a second defogging flow path allowing air passing through the cooling heat exchanger or the heating heat exchanger to be mixed and discharged therethrough.

Abstract: A combined RFID and wireless charging electromagnetic wave absorber, a combined RFID and wireless charging wireless antenna including same, and a method for manufacturing same. The electromagnetic wave absorber not only performs separate functions of RFID and wireless charging and provides stable operating characteristics, but also has a structure in which an electromagnetic wave absorber and a wireless antenna are integrally coupled so as to maximize the respective performance thereof. Despite a structure in which the two functions of RFID and wireless charging are combined, the thickness of the antenna can be reduced, such that it can be very useful when adopted in and applied to a mobile device, thereby contributing greatly to reducing the thickness of a smartphone.

Abstract: Provided are an alignment mark with a higher rate of recognition, a semiconductor chip including the alignment mark, a semiconductor package including the semiconductor chip, and methods of fabricating the alignment mark, the semiconductor chip, and the semiconductor package. The alignment mark may include an align metal pad on a substrate and may be electrically isolated. A protective film may be on the align metal pad and may include an aperture exposing a part of the align metal pad. A metal alignment bump may be on the align metal pad exposed in the aperture such that the metal alignment bump protrudes above the protective film.

Abstract: 0A method for treating or preventing an elevated blood lipid level-related disease in a mammal, which comprises administering thereto an effective amount of rutin, quercetin or a mixture thereof.

Abstract: A method for treating or preventing an elevated blood lipid level-related disease in a mammal, which comprises administering thereto an effective amount of rutin, quercetin or a mixture thereof.

Abstract: The present invention relates to a spice composition comprising 1 to 30 % by weight of garlic, 10 to 50% by weight of onion, 0.2 to 10% by weight of ginger, 5 to 40% by weight of jujube, and 10 to 50% by weight of citrus peel or an extract thereof or 1 to 20% by weight of naringin or hesperidin.

Abstract: A method for treating or preventing an elevated blood lipid level-related disease such as hyperlipidemia, arteriosclerosis, angina pectoris, stroke and hepatic diseases in a mammal, which comprises administering thereto an effective amount of a cinnamic acid derivative of formula Ia or Ib, or a pharmaceutically acceptable salt thereof: wherein, R1, R2, R3, R4 and R5 are independently H, OH or C1-4 alkoxy; and R6 is H, C1-4 alkyl group, or C5-7 cycloalkyl group having one or more substituents selected from the group consisting of OH, alkoxy and carboxy groups.

Abstract: A method for treating or preventing an elevated blood lipid level-related disease in a mammal, which comprises administering thereto an effective amount of rutin, quercetin or a mixture thereof.

Abstract: Methods for inhibiting the activity of acyl CoA-cholesterol-o-acyltransferase, inhibiting the accumulation of macrophage-lipid complex on the arterial endothelium, and preventing or treating hepatic diseases in a mammal comprise administering a citrus peel extract thereto.

Abstract: Method for inhibiting the formation of fatty streak on the arterial endothelium in a mammal comprise administering a citrus peel extract or citrus peel powder thereto.

Abstract: Methods for inhibiting the activity of acyl CoA-cholesterol-o-acyltransferase, inhibiting the accumulation of macrophage-lipid complex on the arterial endothelium, and preventing or treating hepatic diseases in a mammal comprise administering naringin or naringenin thereto.

Abstract: A method for treating or preventing an elevated blood lipid level-related diseases such as hyperlipidemia, arteriosclerosis, angina pectoris, stroke and hepatic diseases in a mammal, which comprises administering thereto an effective amount of tannin, gallic acid or ellagic acid.

Abstract: A method for lowering the blood glucose level in a mammal comprises administering an effective amount of a hesperetin or naringenin bioflavonoid.

Abstract: A peptide consisting of the following amino acid sequence, or an analogue or a fragment thereof, has an inhibitory activity on cholesteryl ester transfer protein:Glu Asp Thr Ser Pro Glu Asp Lys Met Gln Asp Tyr Val Lys Gln Ala Thr Arg Thr Ala Gln Asp Ala Leu Thr Ser Val Lys.

Abstract: A method for inhibiting the activity of 3-hydroxy-3-methylglutaryl CoA(HMG--CoA) reductase in mammals is disclosed comprising administering naringin or naringenin thereto.

Abstract: A method for inhibiting the activity of 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase in mammals comprises administering citrus peel extract thereto.

Abstract: A method for inhibiting the activity of 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase in mammals comprises administering hesperidin or hesperetin thereto.